CN Stock MarketDetailed Quotes

002728 Teyi Pharmaceutical Group

Watchlist
  • 7.99
  • +0.06+0.76%
Market Closed Aug 8 15:00 CST
4.08BMarket Cap39.36P/E (TTM)

Teyi Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-41.72%313.75M
-45.88%164.61M
20.38%1.07B
27.83%745.29M
39.79%538.38M
56.50%304.16M
16.94%886.57M
10.96%583.05M
7.51%385.14M
-0.02%194.35M
Operating revenue
-41.72%313.75M
-45.88%164.61M
20.38%1.07B
27.83%745.29M
39.79%538.38M
56.50%304.16M
16.94%886.57M
10.96%583.05M
7.51%385.14M
-0.02%194.35M
Other operating revenue
18.25%472.19K
----
74.15%741.44K
----
96.55%399.33K
----
84.10%425.74K
----
41.75%203.17K
----
Total operating cost
-12.17%318.75M
-13.39%156.73M
10.23%768.83M
10.40%530.07M
14.41%362.94M
29.16%180.96M
15.65%697.48M
13.59%480.12M
11.50%317.22M
-10.75%140.11M
Operating cost
-14.59%189.65M
-18.88%91.71M
3.58%467.99M
2.74%315.31M
8.61%222.05M
22.03%113.06M
26.89%451.83M
23.87%306.91M
25.87%204.45M
6.65%92.65M
Operating tax surcharges
-41.25%3.31M
-52.42%1.56M
24.46%12.28M
26.44%7.78M
35.39%5.63M
43.37%3.28M
6.40%9.87M
0.41%6.15M
6.71%4.16M
2.13%2.29M
Operating expense
-12.84%70.26M
1.51%36.07M
48.52%174.36M
57.60%121.72M
73.50%80.62M
114.98%35.53M
-1.13%117.4M
-1.63%77.23M
-17.39%46.47M
-48.74%16.53M
Administration expense
12.19%34.42M
7.56%17.6M
12.43%66.31M
13.01%47.18M
10.91%30.68M
20.62%16.36M
3.09%58.99M
-0.78%41.74M
-0.44%27.66M
-3.49%13.57M
Financial expense
-113.39%-546.77K
-151.80%-1.32M
-77.44%4.82M
-72.13%5.62M
-75.25%4.08M
-60.49%2.54M
-10.90%21.39M
-6.79%20.16M
2.09%16.5M
-50.32%6.43M
-Interest expense (Financial expense)
-64.73%3.37M
-65.48%1.39M
-43.83%16.36M
-43.14%14.03M
-48.34%9.55M
-43.17%4.02M
-1.29%29.13M
-1.94%24.68M
-2.06%18.49M
-47.11%7.07M
-Interest Income (Financial expense)
25.40%-4.25M
-86.09%-2.81M
-45.87%-11.98M
-75.63%-8.74M
-139.55%-5.7M
-111.40%-1.51M
-40.84%-8.21M
-28.71%-4.97M
20.67%-2.38M
-12.27%-715.52K
Research and development
8.95%21.66M
9.02%11.1M
13.30%43.06M
16.29%32.47M
10.48%19.88M
17.71%10.18M
0.62%38.01M
5.12%27.92M
0.08%17.99M
0.19%8.65M
Credit Impairment Loss
10.75%1.9M
-45.22%1.53M
97.62%-35.01K
869.74%1.46M
338.68%1.71M
925.10%2.8M
18.94%-1.47M
83.34%-189.8K
-699.46%-718.26K
31.25%-339.31K
Asset Impairment Loss
----
----
---13.16M
----
----
----
----
----
----
----
Other net revenue
76.75%6.55M
-10.79%3.43M
-168.51%-5.11M
-41.39%4.63M
-31.88%3.71M
1,186.71%3.85M
151.41%7.46M
-9.60%7.9M
-41.66%5.44M
-95.21%298.95K
Invest income
--1.05M
--21.47K
6.29%360.81K
-20.44%270.08K
----
----
-94.62%339.46K
-94.62%339.46K
-95.84%262.39K
----
Asset deal income
-99.83%204.42
----
199.24%122.08K
195.67%120.63K
392.29%120.36K
----
-57.20%40.8K
--40.8K
--24.45K
----
Other revenue
92.63%3.61M
79.22%1.88M
-11.02%7.6M
-63.96%2.78M
-68.11%1.87M
64.04%1.05M
113.62%8.55M
115.89%7.71M
102.40%5.87M
15.56%638.25K
Operating profit
-99.13%1.55M
-91.10%11.31M
49.21%293.27M
98.37%219.85M
144.22%179.15M
132.95%127.04M
39.82%196.55M
-0.63%110.83M
-11.69%73.36M
24.98%54.54M
Add:Non operating Income
-75.56%1.72K
-98.07%120.29
44.07%106.8K
-89.63%7.33K
-90.01%7.04K
-68.82%6.24K
-99.03%74.13K
-99.04%70.74K
-98.95%70.45K
-99.71%20K
Less:Non operating expense
482.51%457.4K
363.02%119.13K
29.20%384.25K
-11.01%158.52K
-55.92%78.52K
-85.14%25.73K
-72.35%297.4K
-75.36%178.14K
-35.00%178.14K
15.39%173.09K
Total profit
-99.39%1.1M
-91.19%11.19M
49.24%292.99M
98.42%219.7M
144.48%179.08M
133.57%127.02M
33.46%196.32M
-6.33%110.72M
-18.19%73.25M
8.07%54.38M
Less:Income tax cost
-105.91%-1.59M
-90.54%2.04M
119.74%39.82M
140.91%31.22M
128.67%26.96M
147.22%21.55M
-10.21%18.12M
-15.54%12.96M
-17.10%11.79M
0.75%8.72M
Net profit
-98.23%2.69M
-91.32%9.15M
42.07%253.18M
92.79%188.48M
147.51%152.13M
130.96%105.47M
40.41%178.2M
-4.96%97.77M
-18.39%61.46M
9.59%45.67M
Net profit from continuing operation
-98.23%2.69M
-91.32%9.15M
42.07%253.18M
92.79%188.48M
147.51%152.13M
130.96%105.47M
40.41%178.2M
-4.96%97.77M
-18.39%61.46M
9.59%45.67M
Net profit of parent company owners
-98.23%2.69M
-91.32%9.15M
42.07%253.18M
92.79%188.48M
147.51%152.13M
130.96%105.47M
40.41%178.2M
-4.96%97.77M
-18.39%61.46M
9.59%45.67M
Earning per share
Basic earning per share
-98.53%0.005
-90.91%0.03
35.09%0.77
84.38%0.59
70.00%0.34
57.14%0.33
-8.06%0.57
-37.25%0.32
-45.95%0.2
5.00%0.21
Diluted earning per share
-98.48%0.005
-90.63%0.03
35.09%0.77
78.13%0.57
65.00%0.33
60.00%0.32
-8.06%0.57
-37.25%0.32
-45.95%0.2
0.00%0.2
Other composite income
Total composite income
-98.23%2.69M
-91.32%9.15M
42.07%253.18M
92.79%188.48M
147.51%152.13M
130.96%105.47M
40.41%178.2M
-4.96%97.77M
-18.39%61.46M
9.59%45.67M
Total composite income of parent company owners
-98.23%2.69M
-91.32%9.15M
42.07%253.18M
92.79%188.48M
147.51%152.13M
130.96%105.47M
40.41%178.2M
-4.96%97.77M
-18.39%61.46M
9.59%45.67M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -41.72%313.75M-45.88%164.61M20.38%1.07B27.83%745.29M39.79%538.38M56.50%304.16M16.94%886.57M10.96%583.05M7.51%385.14M-0.02%194.35M
Operating revenue -41.72%313.75M-45.88%164.61M20.38%1.07B27.83%745.29M39.79%538.38M56.50%304.16M16.94%886.57M10.96%583.05M7.51%385.14M-0.02%194.35M
Other operating revenue 18.25%472.19K----74.15%741.44K----96.55%399.33K----84.10%425.74K----41.75%203.17K----
Total operating cost -12.17%318.75M-13.39%156.73M10.23%768.83M10.40%530.07M14.41%362.94M29.16%180.96M15.65%697.48M13.59%480.12M11.50%317.22M-10.75%140.11M
Operating cost -14.59%189.65M-18.88%91.71M3.58%467.99M2.74%315.31M8.61%222.05M22.03%113.06M26.89%451.83M23.87%306.91M25.87%204.45M6.65%92.65M
Operating tax surcharges -41.25%3.31M-52.42%1.56M24.46%12.28M26.44%7.78M35.39%5.63M43.37%3.28M6.40%9.87M0.41%6.15M6.71%4.16M2.13%2.29M
Operating expense -12.84%70.26M1.51%36.07M48.52%174.36M57.60%121.72M73.50%80.62M114.98%35.53M-1.13%117.4M-1.63%77.23M-17.39%46.47M-48.74%16.53M
Administration expense 12.19%34.42M7.56%17.6M12.43%66.31M13.01%47.18M10.91%30.68M20.62%16.36M3.09%58.99M-0.78%41.74M-0.44%27.66M-3.49%13.57M
Financial expense -113.39%-546.77K-151.80%-1.32M-77.44%4.82M-72.13%5.62M-75.25%4.08M-60.49%2.54M-10.90%21.39M-6.79%20.16M2.09%16.5M-50.32%6.43M
-Interest expense (Financial expense) -64.73%3.37M-65.48%1.39M-43.83%16.36M-43.14%14.03M-48.34%9.55M-43.17%4.02M-1.29%29.13M-1.94%24.68M-2.06%18.49M-47.11%7.07M
-Interest Income (Financial expense) 25.40%-4.25M-86.09%-2.81M-45.87%-11.98M-75.63%-8.74M-139.55%-5.7M-111.40%-1.51M-40.84%-8.21M-28.71%-4.97M20.67%-2.38M-12.27%-715.52K
Research and development 8.95%21.66M9.02%11.1M13.30%43.06M16.29%32.47M10.48%19.88M17.71%10.18M0.62%38.01M5.12%27.92M0.08%17.99M0.19%8.65M
Credit Impairment Loss 10.75%1.9M-45.22%1.53M97.62%-35.01K869.74%1.46M338.68%1.71M925.10%2.8M18.94%-1.47M83.34%-189.8K-699.46%-718.26K31.25%-339.31K
Asset Impairment Loss -----------13.16M----------------------------
Other net revenue 76.75%6.55M-10.79%3.43M-168.51%-5.11M-41.39%4.63M-31.88%3.71M1,186.71%3.85M151.41%7.46M-9.60%7.9M-41.66%5.44M-95.21%298.95K
Invest income --1.05M--21.47K6.29%360.81K-20.44%270.08K---------94.62%339.46K-94.62%339.46K-95.84%262.39K----
Asset deal income -99.83%204.42----199.24%122.08K195.67%120.63K392.29%120.36K-----57.20%40.8K--40.8K--24.45K----
Other revenue 92.63%3.61M79.22%1.88M-11.02%7.6M-63.96%2.78M-68.11%1.87M64.04%1.05M113.62%8.55M115.89%7.71M102.40%5.87M15.56%638.25K
Operating profit -99.13%1.55M-91.10%11.31M49.21%293.27M98.37%219.85M144.22%179.15M132.95%127.04M39.82%196.55M-0.63%110.83M-11.69%73.36M24.98%54.54M
Add:Non operating Income -75.56%1.72K-98.07%120.2944.07%106.8K-89.63%7.33K-90.01%7.04K-68.82%6.24K-99.03%74.13K-99.04%70.74K-98.95%70.45K-99.71%20K
Less:Non operating expense 482.51%457.4K363.02%119.13K29.20%384.25K-11.01%158.52K-55.92%78.52K-85.14%25.73K-72.35%297.4K-75.36%178.14K-35.00%178.14K15.39%173.09K
Total profit -99.39%1.1M-91.19%11.19M49.24%292.99M98.42%219.7M144.48%179.08M133.57%127.02M33.46%196.32M-6.33%110.72M-18.19%73.25M8.07%54.38M
Less:Income tax cost -105.91%-1.59M-90.54%2.04M119.74%39.82M140.91%31.22M128.67%26.96M147.22%21.55M-10.21%18.12M-15.54%12.96M-17.10%11.79M0.75%8.72M
Net profit -98.23%2.69M-91.32%9.15M42.07%253.18M92.79%188.48M147.51%152.13M130.96%105.47M40.41%178.2M-4.96%97.77M-18.39%61.46M9.59%45.67M
Net profit from continuing operation -98.23%2.69M-91.32%9.15M42.07%253.18M92.79%188.48M147.51%152.13M130.96%105.47M40.41%178.2M-4.96%97.77M-18.39%61.46M9.59%45.67M
Net profit of parent company owners -98.23%2.69M-91.32%9.15M42.07%253.18M92.79%188.48M147.51%152.13M130.96%105.47M40.41%178.2M-4.96%97.77M-18.39%61.46M9.59%45.67M
Earning per share
Basic earning per share -98.53%0.005-90.91%0.0335.09%0.7784.38%0.5970.00%0.3457.14%0.33-8.06%0.57-37.25%0.32-45.95%0.25.00%0.21
Diluted earning per share -98.48%0.005-90.63%0.0335.09%0.7778.13%0.5765.00%0.3360.00%0.32-8.06%0.57-37.25%0.32-45.95%0.20.00%0.2
Other composite income
Total composite income -98.23%2.69M-91.32%9.15M42.07%253.18M92.79%188.48M147.51%152.13M130.96%105.47M40.41%178.2M-4.96%97.77M-18.39%61.46M9.59%45.67M
Total composite income of parent company owners -98.23%2.69M-91.32%9.15M42.07%253.18M92.79%188.48M147.51%152.13M130.96%105.47M40.41%178.2M-4.96%97.77M-18.39%61.46M9.59%45.67M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Daishin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg